Test Price
700 AED✅ Home Collection Available
HLA-DRB1*1501 Genotyping (Multiple Sclerosis) in UAE | 700 AED | 2026 DHA Guidelines
تحليل HLA-DRB1*1501 (التصلب المتعدد) في الإمارات | 700 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM–11 PM).
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed specialists.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
يُجرى هذا الفحص الجيني بدقة عالية تصل إلى 99.9% وفق معايير الآيزو الدولية، مع خدمة سحب دم منزلي بنظام التبريد المعتمد، وتوفير استشارة هاتفية بعد النتيجة، بالإضافة إلى تسهيلات التأمين الصحي عبر الواتساب.
Overview of HLA-DRB1*1501 Genotyping
HLA-DRB1*1501 genotyping is a DNA-based assay that detects the strongest genetic susceptibility allele for multiple sclerosis, enabling personalised risk assessment and clinical decision-making. يكشف هذا التحليل عن الأليل الجيني الأكثر ارتباطاً بمرض التصلب المتعدد، مما يساعد في تقييم المخاطر الفردية وخطط المتابعة السريرية.
| Feature | Our Test HLA-DRB1*1501 Genotyping |
Closest Alternative Multiplex HLA Panel |
|---|---|---|
| Methodology | Sanger Sequencing (gold standard) | PCR-SSP / Luminex |
| Target Precision | High-resolution allele-specific (*1501) | Low/medium resolution broad typing |
| Turnaround Time | 10 days | 14–21 days |
| Price | 700 AED | 1,200+ AED |
*Comparison based on typical UAE laboratory market data. Our test focused solely on the clinically actionable DRB1*1501 allele, reducing cost and turnaround.
Physician Insight & Safety Protocol
“As a DHA-licensed specialist, I emphasise that carrying HLA-DRB1*1501 does not mean you will develop multiple sclerosis. This genetic finding must be interpreted alongside your neurological examination, family history, and MRI findings. Please use this report as one piece of a comprehensive risk evaluation, never as a standalone diagnosis.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic results do not replace ongoing treatment plans.
Exclusion Criteria & Emergency Red Flags
- Not for minors without legal guardian consent (UAE CDS Law 2026).
- Not intended for emergency diagnosis of acute neurological symptoms.
- Home collection not advised for individuals with severe bleeding disorders or uncontrolled seizures without prior clinical clearance.
- Seek immediate medical care if you experience: sudden vision loss, slurred speech, limb paralysis, or bladder/bowel dysfunction.
Patient FAQ & Clinical Guidance
1. What is the clinical significance of HLA-DRB1*1501 in multiple sclerosis?
HLA-DRB1*1501 is the strongest genetic risk factor for multiple sclerosis, increasing susceptibility two- to threefold. It plays a role in immune dysregulation by presenting myelin-derived peptides to T‑cells. However, additional environmental triggers (e.g., Epstein‑Barr virus, low vitamin D, smoking) are typically required for disease manifestation. Genetic counselling is recommended before and after testing to understand its implications for family members.
يُعد أليل HLA-DRB1*1501 أقوى عامل وراثي مرتبط بالتصلب المتعدد، حيث يزيد القابلية للإصابة بمقدار ضعفين إلى ثلاثة أضعاف، لكنه لا يكفي وحده للتسبب بالمرض دون عوامل بيئية أخرى.
2. How should I prepare for the blood draw?
No fasting is required; simply maintain good hydration and inform the phlebotomist of any prescribed anticoagulants. The sample is collected via standard venipuncture (whole blood) using a cold-chain kit provided by our mobile team. If you have a history of difficult veins, we advise drinking water 30 minutes beforehand. All collection materials are ISO-certified and single-use.
لا داعي للصيام قبل التحليل، يُنصح بشرب الماء لإبقاء الأوردة ممتلئة، وإعلام الممرض بأي أدوية مضادة للتخثر.
3. Can this test diagnose multiple sclerosis?
No, this assesses genetic predisposition only; a definitive MS diagnosis requires neurological exam, MRI, and CSF analysis. It is a susceptibility marker, not a diagnostic biomarker. A negative result does not rule out MS, and a positive result does not confirm MS. Always follow up with a consultant neurologist for a comprehensive work-up using the 2017 McDonald criteria.
هذا الفحص ليس أداة تشخيصية، بل يقيس القابلية الجينية فقط. التشخيص المؤكد يعتمد على الفحص العصبي والرنين المغناطيسي وفحص السائل النخاعي.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians